Publication: Docking study on anticancer activity of chromone derivatives
1
Issued Date
2013-01-01
Resource Type
ISSN
15548120
10542523
10542523
Other identifier(s)
2-s2.0-84872046737
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Medicinal Chemistry Research. Vol.22, No.1 (2013), 45-56
Suggested Citation
Chirattikarn Maicheen, Narumol Phosrithong, Jiraporn Ungwitayatorn Docking study on anticancer activity of chromone derivatives. Medicinal Chemistry Research. Vol.22, No.1 (2013), 45-56. doi:10.1007/s00044-012-0009-y Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/31560
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Docking study on anticancer activity of chromone derivatives
Other Contributor(s)
Abstract
Several phenyl substituted chromones (also called flavonoids) have been reported to possess substantial anticancer properties; however, their modes of action have not been clearly defined. To preliminarily investigate the potential anticancer activity and mode of action of some synthetic chromone derivatives, the docking was performed using different enzymes and receptor proteins involved with cancer cell cycle, cell growth, and DNA replication, i.e., cyclin-dependent protein kinase-2 (CDK-2), CDK-6, DNA topoisomerases I and II, B-cell lymphoma-2 (Bcl-2), vascular endothelial growth factor receptor-2 (VEGFR-2), and the telomere: G-quadruplexes. The docking results revealed that chromone 32 exhibited better binding interactions to CDK-2 and Bcl-2 than the known CDK-2 and Bcl-2 inhibitors. Chromone 39 was found to bind to CDK-6 with tighter interaction than several reported CDK-6 inhibitors. Chromone 47 was best bound to both DNA topoisomerases I and II. Chromones 24 and 15 showed good binding interaction with VEGFR-2 and telomere: G-quadruplex, respectively. The inhibition constants (Ki) of each chromone compound against each target molecule were calculated. These Kivalues could be used as a preliminary tool for screening specific inhibitors before performing experimental activity assay. © 2012 Springer Science+Business Media, LLC.